Latest News

Latest News

News from the World Hepatitis Alliance

Viral Hepatitis kills more people than HIV, malaria or tuberculosis

15 Sep 2017 Tara Farrell

World Hepatitis Alliance calls for immediate political action to counteract fatal trend [London, 14 September] According to the Global Burden of...

Hepatitis A vaccination for Alaskan children has wiped out the virus

10 Aug 2017 Tara Farrell

A comprehensive hepatitis A vaccination program established in Alaska in the 1990s, which became a requirement for school entry in 2001, has...

Study shows universal vaccination has wiped out hepatitis B and associated liver cancer in Alaska’s young people

10 Aug 2017 Tara Farrell

Updated research presented at this year’s World Indigenous Peoples’ Conference on Viral Hepatitis in Anchorage, Alaska, USA (8-9 August) shows that...

New research shows indigenous peoples are much more likely to be infected by hepatitis B and/or C

9 Aug 2017 Bridie Taylor

A new meta-analysis of global hepatitis data -- presented at this year's World Indigenous Peoples' Conference on Viral Hepatitis in Anchorage, Alaska...

Cherokee Nation American Indian Tribe showing it is possible to eliminate hepatitis C

9 Aug 2017 Bridie Taylor

The Cherokee Nation American Indian population is aiming to eliminate hepatitis C virus (HCV) among its tribal citizens, where already almost half...

World Hepatitis Day sets the stage for the elimination of viral hepatitis - Press Release

28 Jul 2017 Tara Farrell

World Hepatitis Alliance calls for greater collaboration to reach 2030 World Health Organization targets...

An open letter to the Cochrane Collaboration

26 Jun 2017 Bridie Taylor

The members of the Executive Board of the World Hepatitis Alliance are elected to represent the more than 300 million people who have the experience...

“Findings from hepatitis C study should not deter patients from seeking treatment or governments from funding it” says World Hepatitis Alliance

13 Jun 2017 Tara Farrell

The World Hepatitis Alliance is concerned that the findings of the Cochrane Review on the new direct acting antiviral (DAA) hepatitis C drugs could...

World Hepatitis Alliance seeks Communications and Campaigns Officer

9 Jun 2017 Tara Farrell

Our dynamic Communications team is seeking an experienced Communications and Campaigns Officer to develop and implement our external facing...

Why do we continue to put our children at unnecessary risk of liver cancer?

6 Jun 2017 Bridie Taylor

On International Children’s Day (1June), the World Hepatitis Alliance calls for widespread coverage of the hepatitis B birth dose vaccine to protect...

WHO’s first Global Hepatitis Report sets baseline to measure progress towards the elimination of viral hepatitis by 2030

21 Apr 2017 Tara Farrell

London, 21 April 2017, The World Hepatitis Alliance today welcomes the publication of the first-ever Global Hepatitis Report by the World Health Organization (WHO). The report comes as a follow-up to WHO’s Global Strategy on Viral Hepatitis, which set a goal of eliminating viral hepatitis as a public health threat by 2030....

ZERO DISCRIMINATION DAY: FEAR AND IGNORANCE ROBS PEOPLE OF JOBS, EDUCATION OPPORTUNITIES, FRIENDSHIPS AND RELATIONSHIPS

1 Mar 2017 Bridie Taylor

People living with viral hepatitis are subject to stigma and discrimination in almost every aspect of their lives. Fear and ignorance have robbed...

World Day of Social Justice: fighting for our right to health

20 Feb 2017 Tara Farrell

By Raquel Peck By the time you finish reading this blog, a man, woman or child will have died from viral hepatitis; a disease which can either be...

World Hepatitis Alliance President-Elect announced

26 Jan 2017 Bridie Taylor

Michael Ninburg appointed as WHA President-Elect Today, the World Hepatitis Alliance (WHA) Executive Board announced that, following a comprehensive...

Elimination to take centre stage at APASL 2017

24 Jan 2017 Bridie Taylor

The elimination of viral hepatitis to dominate discussions at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL...

Industry and civil Society unite to help deliver hepatitis C medication in low-and middle-income countries

18 Jan 2017 Tara Farrell

Today, MasterCard signed a Memorandum of Understanding (MoU) with Gilead Sciences, Inc. to explore, in a pilot programme, the potential of using the...

India’s young filmmakers give a global voice to viral hepatitis survivors

14 Dec 2016 Tara Farrell

Today, media charity tve today launches four powerful films that give voice to five individuals in India who have survived viral hepatitis, one of...

Leave no-one behind

2 Dec 2016 Tara Farrell

On 3rd December, patients across the globe will unite to mark Patient Solidarity Day and reaffirm that patient-centred universal health coverage is...

HIV coinfection more than triples the risk of liver disease, liver failure and liver-related death from viral hepatitis

1 Dec 2016 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2016 –...

New WHA Executive Board announced

28 Nov 2016 Bridie Taylor

Our voting members have spoken and the votes have been counted! Following a fiercely contested election, we are delighted to announce our new...

Pages

News from infohep

High prices of DAAs mean there's been little progress towards achieving WHO target of eliminating HCV by 2030

13 Sep 2017 Michael Carter
Only a handful of countries are on course to achieve the World Health Organization (WHO) target of eliminating hepatitis C virus (HCV) as a major...

The availability of direct-acting antivirals is reducing disparities in the uptake of hepatitis C treatment

30 Aug 2017 Roger Pebody
An analysis from British Columbia, Canada shows that older people, individuals with HIV co-infection, people with cirrhosis and – to some extent –...

Liver fibrosis speeds up around the menopause in women with HIV and HCV co-infection

22 Aug 2017 Michael Carter
Menopause is associated with accelerated liver fibrosis in women with HIV and hepatitis C virus (HCV) co-infection, investigators from the United...

People with HIV are at risk for liver fibrosis and steatosis

21 Aug 2017 Michael Carter
Metabolic syndrome, type 2 diabetes and obesity are risk factors for the development of liver fibrosis and steatosis (liver fat accumulation) in...

Switching from efavirenz to raltegravir leads to significant improvements in fatty liver disease in people with HIV

17 Aug 2017 Michael Carter
Switching to raltegravir from efavirenz is associated with significant improvements in liver steatosis for HIV-positive people with non-alcoholic...

Treatment with DAAs reduces the risk of mortality in the first 18 months after the completion of treatment

10 Aug 2017 Michael Carter
For the first time, a large study has demonstrated that treatment with direct-acting antivirals (DAAs) significantly reduces mortality rates among...

European and US regulators approve AbbVie's new combo for all hepatitis C genotypes

8 Aug 2017 Liz Highleyman
The European Commission and the US Food and Drug Administration (FDA) last week approved AbbVie's new combination pill for people with hepatitis...

Countries and donors should aim for new $90-$90-$90 target on HIV, hepatitis, TB drug prices, study shows

27 Jul 2017 Keith Alcorn
HIV, hepatitis B and C and tuberculosis (TB) can each be treated for less than $90 a year where generic drugs can be made available, Dzintars Gotham...

Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection

26 Jul 2017 Liz Highleyman
AbbVie's new pangenotypic regimen combining glecaprevir and pibrentasvir cured almost all HIV-positive people with hepatitis C co-infection in...

Hepatitis C treatment is effective and feasible in Africa

25 Jul 2017 Liz Highleyman
Treatment for hepatitis C in sub-Saharan Africa can produce cure rates as high as those seen in industrialised countries, with high adherence and...